Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (55,486,000) $ (3,481,000)
Adjustments to reconcile net loss to net cash used in operating activities    
Loss on remeasurement of private warrants (21,957,000) 0
Share-based compensation 20,696,000 302,000
Depreciation and amortization 4,311,000 1,809,000
Loss on write-off of deferred loan costs 1,900,000 0
Amortization of debt issuance costs and debt discounts 207,000 852,000
Single lease cost (benefit) (806,000) 194,000
Gain on forgiveness of debt 1,776,000 0
Other 66,000 381,000
Changes in operating assets and liabilities - net of acquisitions:    
Accounts payable 1,967,000 (592,000)
Contract assets (1,552,000) 0
Unearned revenue and contract liabilities (1,633,000) (907,000)
Prepaid expenses and other current assets (1,520,000) (1,879,000)
Accounts receivable, net (3,464,000) (1,152,000)
Accrued and other long-term liabilities (3,537,000) 346,000
Inventories (4,011,000) (5,780,000)
Other assets 40,000 (482,000)
Net cash used in operating activities (22,641,000) (10,389,000)
Cash flows from investing activities    
Purchases of property, plant and equipment (51,906,000) (19,079,000)
Proceeds from Sale of Property, Plant, and Equipment 340,000 9,000
Net cash used in investing activities (51,566,000) (19,070,000)
Cash flows from financing activities    
Proceeds from exercise of warrants, net of issuance costs 138,202,000 0
Proceeds from exercise of stock options 2,375,000 0
Proceeds from long-term debt 169,000 4,015,000
Proceeds from employee stock purchase plan 92,000 0
Proceeds from issuance of common stock, net of issuance costs (890,000) 25,007,000
Cash paid for debt issuance costs (1,684,000) (18,000)
Principal payments on long-term debt (27,075,000) (811,000)
Net cash (used in) provided by financing activities 111,189,000 28,193,000
Net (decrease) increase in cash and cash equivalents and restricted cash 36,982,000 (1,266,000)
Cash and cash equivalents and restricted cash    
Cash and cash equivalents and restricted cash-beginning of period 379,897,000 9,278,000
Cash and cash equivalents and restricted cash-end of period 416,879,000 8,012,000
Supplemental Cash Flow Information [Abstract]    
Cash paid for interest, net of interest capitalized 242,000 0
Cash paid for operating leases 1,589,000 1,270,000
Noncash Investing and Financing Items [Abstract]    
Changes in accounts payable and accrued liabilities related to purchase of property, plant and equipment $ 5,983,000 $ (5,831,000)